We are live on ! Find out more
DP

DSAM Partners Portfolio holdings

AUM $176M
1-Year Est. Return 83.78%
This Fund
S&P 500
This Quarter Est. Return
+12.83%
1 Year Est. Return
+83.78%
3 Year Est. Return
+343.2%
5 Year Est. Return
+1,202.92%
10 Year Est. Return
–
AUM
$595M
AUM Growth
+$56.2M
Cap. Flow
+$8.25M
Cap. Flow %
1.39%
Top 10 Hldgs %
57.82%
Holding
59
New
12
Increased
6
Reduced
16
Closed
14

Top Buys

Rank Stock Value
1
VYX icon
NCR Voyix
VYX
+$29.5M
2
STLA icon
Stellantis
STLA
+$24M
3
XPO icon
XPO
XPO
+$21.3M
4
PTON icon
Peloton Interactive
PTON
+$19.2M
5
INTU icon
Intuit
INTU
+$18.9M

Top Sells

Rank Stock Value
1
ON icon
ON Semiconductor
ON
+$22.6M
2
GFL icon
GFL Environmental
GFL
+$16.4M
3
MU icon
Micron Technology
MU
+$13.3M
4
DMYQ.U
dMY Technology Group, Inc. IV Units, each consisting of one share of Class A common stock and one-fi
DMYQ.U
+$12.5M
5
TMPO
Tempo Automation Holdings, Inc. Common Stock
TMPO
+$12.2M

Sector Composition

Rank Sector Weight
1 Technology 30.25%
2 Consumer Discretionary 20.11%
3 Industrials 14.23%
4 Energy 12.61%
5 Communication Services 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRYS icon
26
Krystal Biotech
KRYS
$10.5B
$4.78M 0.8%
70,274
– –
IONQ icon
27
IonQ
IONQ
$12.6B
$4.56M 0.77%
426,732
-360,063
-46% -$3.73M
CLDX icon
28
Celldex Therapeutics
CLDX
$2.76B
$4.54M 0.76%
135,907
– –
MELI icon
29
Mercado Libre
MELI
$94.7B
$3.89M 0.65%
2,500
-300
-11% -$440K
NBIS
30
Nebius Group N.V.
NBIS
$43.3B
$3.89M 0.65%
+55,000
New +$3.61M
ALLO icon
31
Allogene Therapeutics
ALLO
$563M
$3.76M 0.63%
144,000
-41,142
-22% -$1.17M
EPAM icon
32
EPAM Systems
EPAM
$5.23B
$3.32M 0.56%
6,500
-1,500
-19% -$703K
MLM icon
33
Martin Marietta Materials
MLM
$34.7B
$2.83M 0.48%
8,057
-8,715
-52% -$3.1M
VMC icon
34
Vulcan Materials
VMC
$37.3B
$2.2M 0.37%
12,647
-16,309
-56% -$2.92M
IOVA icon
35
Iovance Biotherapeutics
IOVA
$2.15B
$2.12M 0.36%
81,627
– –
IMTX icon
36
Immatics
IMTX
$1.12B
$1.78M 0.3%
152,990
– –
CVE icon
37
Cenovus Energy
CVE
$51.1B
$1.64M 0.28%
+171,000
New +$1.45M
OPCH icon
38
Option Care Health
OPCH
$3.53B
$1.63M 0.27%
74,583
– –
OVV icon
39
Ovintiv
OVV
$16.3B
$1.63M 0.27%
+51,800
New +$1.39M
SUM
40
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.52M 0.26%
44,485
-39,825
-47% -$1.26M
NEXI
41
DELISTED
NexImmune, Inc. Common Stock
NEXI
$1.46M 0.25%
3,580
– –
APLT
42
DELISTED
Applied Therapeutics
APLT
$1.4M 0.23%
67,125
– –
EXP icon
43
Eagle Materials
EXP
$6.85B
$1.37M 0.23%
9,609
-8,975
-48% -$1.29M
AFIB
44
DELISTED
Acutus Medical Inc
AFIB
$1.22M 0.2%
71,848
– –
ARYD
45
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$214K 0.04%
20,000
– –
EEM icon
46
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.2B
– –
-220,000
Closed -$11.7M
HRTX icon
47
Heron Therapeutics
HRTX
$90.8M
– –
-283,415
Closed -$4.59M
JD icon
48
JD.com
JD
$42.9B
– –
-20,000
Closed -$1.69M
KRON
49
DELISTED
Kronos Bio
KRON
– –
-177,426
Closed -$5.19M
ON icon
50
ON Semiconductor
ON
$33.3B
– –
-543,000
Closed -$22.6M
1
2
3

Similar funds

HA
Harborview Advisors Portland, Maine $179M AUM 23.7% 1-Year Est. Return
FWM
Filbrandt Wealth Management Middleton, Wisconsin $174M AUM 35.59% 1-Year Est. Return
MCA
Mercer Capital Advisers Little Silver, New Jersey $187M AUM 24.56% 1-Year Est. Return
NWS
Newport Wealth Strategies Irvine, California $165M AUM 24.55% 1-Year Est. Return
CJA
C-J Advisory San Jose, California $189M AUM 23.84% 1-Year Est. Return
VAM
Velanne Asset Management London, United Kingdom $193M AUM 41.89% 1-Year Est. Return
KGA
KPCB GGF Associates Menlo Park, California $157M AUM
SCM
Symons Capital Management Pittsburgh, Pennsylvania $156M AUM 9.32% 1-Year Est. Return

DSAM Partners's Q2 2021 Portfolio in Review

As of Q2 2021, DSAM Partners held 59 positions worth $595M, up 10% from $539M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

DSAM Partners's Q2 2021 filing shows 12 new, 6 increased, 16 reduced and 14 closed positions. Its largest new stake was NCR Voyix: 1,067,049 shares worth $29.9M. The largest sale was ON Semiconductor, an estimated $22.6M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • DSAM Partners's largest Q2 2021 buy was NCR Voyix: 1,067,049 shares worth $29.9M.
  • DSAM Partners added most to Stem in Q2 2021, an estimated $17.5M increase.
  • DSAM Partners's biggest Q2 2021 reduction was GFL Environmental, cutting an estimated $16.4M.
  • DSAM Partners fully exited ON Semiconductor in Q2 2021, selling an estimated $22.6M.
  • DSAM Partners's ten largest holdings make up 58% of its $595M portfolio in Q2 2021.
  • DSAM Partners opened 12 new positions and closed 14 in Q2 2021.
  • DSAM Partners's portfolio value rose 10% quarter-over-quarter to $595M.

Based on DSAM Partners's 13F filing for Q2 2021, filed 16 Aug 2021.